When Eli Lilly (NYSE: LLY) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the disease, some observers immediately called it a final blow for... Read more »
Dallas—Universities and other institutions are chock-full of intellectual property, but it can be difficult for entrepreneurs, interested in turning those ideas into products, to find what they’re looking for.
Now, a Dallas-based firm called Technium has launched an online matchmaking... Read more »
An average of 24 horses die at U.S. racetracks every week, according to a 2012 New York Times investigation. In some of these cases, catastrophic injuries suffered by horses—which can also cause serious harm to the jockeys riding them—are freak,... Read more »
I’ve got a confession to make: I don’t get Snapchat.
I consider myself a generally tech-savvy person. I own a smartphone, I know my way around your average software program or mobile app, and I’m giddily hoping Santa delivers me an... Read more »
What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress. President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem... Read more »
BrightStar Wisconsin Foundation has invested a combined $550,000 in three Milwaukee-based startups, the nonprofit said Thursday in a news release.
The most recent additions to BrightStar’s portfolio, which now comprises 32 companies, are: Access HealthNet, which gives employees of business... Read more »
A number of companies are pursuing ways to enlist the immune system for treating cancer. Now TCR² Therapeutics is joining the ranks with technology that it says could improve on how the body’s cancer-fighting cells respond to the disease.
Cambridge, MA-based... Read more »
Houston—Vapogenix, a biotech developing a topical non-opioid medication for localized pain, announced Thursday it has raised $8.2 million in a Series C round of funding.
The capital will be used for a Phase 2 proof-of-concept study for its drug candidate,... Read more »
San Antonio — Cytocentrics, the maker of instruments that can be used to screen if and how cells might react to drugs, has changed its name to CytoBioscience.
The name change is happening in part because the San Antonio company is... Read more »
It’s a good day for two young San Francisco digital health companies that combine technology with human workers as they try to help doctors make patient care more effective. Both Augmedix and Vida Health announced double-digit fundraising rounds.
Augmedix, which... Read more »
Nantero, a nanotech company building a new type of computer memory that it says is stronger than steel and less dense than aluminum, has raised $21 million in new financing. The company has now raised $110 million since its founding... Read more »
We’re just one week away from New York Life Sciences 2021, which will take place next Thursday, December 15, at Alexandria Center for Life Science. If you’re already planning on attending, there’s no need to wait any longer—our Procrastinator’s special... Read more »
Speaking at a conference in San Francisco Wednesday, geneticist Craig Venter revealed that he had just had surgery for prostate cancer three weeks ago. A health workup at his own high-end clinic, Health Nucleus, pinpointed the cancer.
Famous for leading one... Read more »